Editorial: Impacts of public-private collaborative research on Alzheimer's disease: the case of the innovative medicines initiative.

Elisabetta Vaudano, Jean Georges, Martin Hofmann-Apitius, Donald Lo
Author Information
  1. Elisabetta Vaudano: The Innovative Health Initiative Joint Undertaking, Brussels, Belgium.
  2. Jean Georges: Alzheimer Europe, Luxembourg, Luxembourg.
  3. Martin Hofmann-Apitius: Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Bonn, Germany.
  4. Donald Lo: EATRIS, Amsterdam, Netherlands.

Abstract

No abstract text available.

Keywords

References

  1. Int J Mol Sci. 2015 Dec 07;16(12):29179-206 [PMID: 26690135]
  2. Lancet Public Health. 2022 Feb;7(2):e105-e125 [PMID: 34998485]
  3. Sci Rep. 2021 May 26;11(1):11049 [PMID: 34040048]
  4. Lancet Neurol. 2023 Sep;22(9):782-783 [PMID: 37463598]
  5. Alzheimers Dement. 2023 Feb;19(2):658-670 [PMID: 35652476]
  6. Patterns (N Y). 2022 Jan 26;3(3):100433 [PMID: 35510183]

Word Cloud

Created with Highcharts 10.0.0Alzheimer'sEditorial:Impactspublic-privatecollaborativeresearchdisease:caseinnovativemedicinesinitiativecollaborationdatasharingdementianetworkspartnershippatient

Similar Articles

Cited By

No available data.